Outputs (27)

Tunnelling-induced wall damage: an appraisal of elastoplastic constitutive models for the masonry (2024)
Journal Article
Yu, Y., Franza, A., Ghiassi, B., Canhoto Neves, L., & Marshall, A. M. (2025). Tunnelling-induced wall damage: an appraisal of elastoplastic constitutive models for the masonry. Tunnelling and Underground Space Technology, 156, Article 106240. https://doi.org/10.1016/j.tust.2024.106240

This paper investigates the role of masonry elastoplastic constitutive models on tunnelling induced damage in buildings. A two-stage analysis method (TSAM) is adopted, incorporating input greenfield displacements, 3D masonry walls, and an elastic mod... Read More about Tunnelling-induced wall damage: an appraisal of elastoplastic constitutive models for the masonry.

Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial (2024)
Journal Article
Harris, V., Holmes, J., Gbinigie, O., Rahman, N. M., Richards, D. B., Hayward, G., Dorward, J., Lowe, D. M., Standing, J. F., Breuer, J., Khoo, S., Petrou, S., Hood, K., Ahmed, H., Carson-Stevens, A., Nguyen-Van-Tam, J. S., Patel, M. G., Saville, B. R., Francis, N., Thomas, N. P. B., …Butler, C. C. (2025). Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial. Lancet Infectious Diseases, 25(1), 68-79. https://doi.org/10.1016/s1473-3099%2824%2900431-6

Background
No randomised controlled trials have yet reported on the effectiveness of molnupiravir on longer term outcomes for COVID-19. The PANORAMIC trial found molnupiravir reduced time to recovery in acute COVID-19 over 28 days. We aimed to repor... Read More about Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial.

Learnings from the vaccines taskforce: an apotheosis in mission, purpose and handling risk (2024)
Journal Article
Carroll, S. M., Van-Tam, J. N., Shaw, I., Todd, R., & Bell, E. (2024). Learnings from the vaccines taskforce: an apotheosis in mission, purpose and handling risk. Journal of Medical Economics (JME), 27(1), 1119-1123. https://doi.org/10.1080/13696998.2024.2395741

The Vaccines Task Force was established by the UK government in April 2020, with the objective of securing early access to effective COVID-19 vaccines for the UK population and internationally. The VTF was successful in securing the earliest access t... Read More about Learnings from the vaccines taskforce: an apotheosis in mission, purpose and handling risk.

Behaviour of Textile Reinforced Concrete panels under high-velocity impact loading (2024)
Journal Article
Esaker, M., Thermou, G. E., & Neves, L. (2024). Behaviour of Textile Reinforced Concrete panels under high-velocity impact loading. Construction and Building Materials, 445, 137806. https://doi.org/10.1016/j.conbuildmat.2024.137806

This study aims to experimentally investigate the impact resistance of Textile Reinforced Concrete (TRC) panels under high-velocity impact loading. 54 control and TRC panels were fabricated using a standard (29 MPa) and a high (101 MPa) compressive s... Read More about Behaviour of Textile Reinforced Concrete panels under high-velocity impact loading.

Uptake, safety and effectiveness of inactivated influenza vaccine in inflammatory bowel disease: a UK-wide study (2024)
Journal Article
Nakafero, G., Grainge, M. J., Card, T., Mallen, C. D., Nguyen Van-Tam, J. S., & Abhishek, A. (2024). Uptake, safety and effectiveness of inactivated influenza vaccine in inflammatory bowel disease: a UK-wide study. BMJ Open Gastroenterology, 11(1), Article e001370. https://doi.org/10.1136/bmjgast-2024-001370

Objective To investigate (1) the UK-wide inactivated influenza vaccine (IIV) uptake in adults with inflammatory bowel disease (IBD), (2) the association between vaccination against influenza and IBD flare and (3) the effectiveness of IIV in preventin... Read More about Uptake, safety and effectiveness of inactivated influenza vaccine in inflammatory bowel disease: a UK-wide study.

Ultra-high surface area ionic-liquid-derived carbons that meet both gravimetric and volumetric methane storage targets (2024)
Journal Article
Albeladi, N., Blankenship, L. S., & Mokaya, R. (2024). Ultra-high surface area ionic-liquid-derived carbons that meet both gravimetric and volumetric methane storage targets. Energy and Environmental Science, https://doi.org/10.1039/d3ee03957a

The storage of methane, to enable vehicular use, may be achieved in porous solids, but to date, there is no material that meets the gravimetric and volumetric targets (for example those set by the US Department of Energy, DOE) for such use. Here, in... Read More about Ultra-high surface area ionic-liquid-derived carbons that meet both gravimetric and volumetric methane storage targets.

Uptake and safety of pneumococcal vaccination in adults with immune mediated inflammatory diseases: a UK wide observational study (2024)
Journal Article
Nakafero, G., Grainge, M. J., Card, T., Mallen, C. D., Nguyen Van-Tam, J. S., Abhishek, A., & . (2024). Uptake and safety of pneumococcal vaccination in adults with immune mediated inflammatory diseases: a UK wide observational study. Rheumatology, Article keae160. https://doi.org/10.1093/rheumatology/keae160

Objective The uptake and safety of pneumococcal vaccination in people with immune mediated inflammatory diseases (IMIDs) is poorly understood. We investigated the UK wide pneumococcal vaccine uptake in adults with IMIDs and explored the association b... Read More about Uptake and safety of pneumococcal vaccination in adults with immune mediated inflammatory diseases: a UK wide observational study.

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients (2024)
Journal Article
Standing, J. F., Buggiotti, L., Guerra-Assunção, J. A., Woodall, M., Ellis, S., Agyeman, A. A., Miller, C., Okechukwu, M., Kirkpatrick, E., Jacobs, A. I., Williams, C. A., Roy, S., Martin-Bernal, L. M., Williams, R., Smith, C. M., Sanderson, T., Ashford, F., Emmanuel, B., Afzal, Z. M., Shields, A., …Breuer, J. (2024). Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. Nature Communications, 15, Article 1652. https://doi.org/10.1038/s41467-024-45641-0

Viral clearance, antibody response and the mutagenic effect of molnupiravir has not been elucidated in at-risk populations. Non-hospitalised participants within 5 days of SARS-CoV-2 symptoms randomised to receive molnupiravir (n=253) or Usual Care (n... Read More about Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.

Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial (2024)
Journal Article
Png, M. E., Harris, V., Grabey, J., Hart, N. D., Jani, B. D., Butler, D., Carson-Stevens, A., Coates, M., Cureton, L., Dobson, M., Dorward, J., Evans, P., Francis, N., Gbinigie, O. A., Hayward, G., Holmes, J., Hood, K., Khoo, S., Ahmed, H., Lown, M., …Petrou, S. (2024). Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial. British Journal of General Practice, 74(745), e570-e579. https://doi.org/10.3399/BJGP.2023.0444

Background The cost-effectiveness of molnupiravir, an oral antiviral for early treatment of SARS-CoV-2, has not been established in vaccinated populations.

Aim To evaluate the cost-effectiveness of molnupiravir relative to usual care alone among m... Read More about Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial.

Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable (2023)
Journal Article
de Waure, C., Gärtner, B. C., Lopalco, P. L., Puig-Barbera, J., & Nguyen-Van-Tam, J. S. (2024). Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable. Expert Review of Vaccines, 23(1), 27-38. https://doi.org/10.1080/14760584.2023.2290194

INTRODUCTION: Influenza causes significant morbidity and mortality, but influenza vaccine uptake remains below most countries' targets. Vaccine policy recommendations vary, as do procedures for reviewing and appraising the evidence. AREAS COVERED: Du... Read More about Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable.